Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2012
03/08/2012US20120058132 Treatment of glycogen storage disease type II
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058113 Cancer treatment method
03/08/2012US20120058093 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
03/08/2012US20120058078 Assay for the detection of factors that modulate the expression of ingap
03/08/2012US20120058063 Process for treating and/or forming a non-newtonian fluid using microchannel process technology
03/08/2012DE102010036198A1 Apparatus for inactivation of multiresistant bacteria in wound treatment in human and veterinary medicine in real time, where a cocktail is generated from highly active components or compounds in situ in nascent state in an aqueous liquid
03/08/2012CA2808908A1 Combination of hdac inhibitors with thrombocytopenia drugs
03/07/2012EP2426145A1 Engineered anti-IL-23p19 antibodies
03/07/2012EP2425859A1 Olmesartan formulations
03/07/2012EP2425858A2 Compositions for treating pain and pruritus
03/07/2012EP2425857A1 Antiparasitic agent for fish and method of controlling proliferation of fish parasites
03/07/2012EP2425843A1 Dentine calcification agent and method for producing same
03/07/2012EP2425841A1 Methods Employing and Compositions Containing Defined Oxidized Phospholipids for Prevention and Treatment of Atherosclerosis
03/07/2012EP2425838A2 Combination therapy for treatment of immune disorders
03/07/2012EP2425833A1 Intravenous application of fish oils / DHA + EPA before or at the beginning of chemotherapy
03/07/2012EP2425827A1 Transdermal preparation
03/07/2012EP2425722A2 Drugs and food products for hypophosphoric normo-, hyper- and hypoproteic diets, and hypophosphoric beverages
03/07/2012EP2424529A2 Novel therapeutic treatments using centhaquin
03/07/2012EP2424527A1 Mast cell stabilizers to prevent or treat laminitis
03/07/2012EP2424518A1 Oral compositions for skin benefits
03/07/2012EP2424516A2 Pentamidine combinations for treating cancer
03/07/2012EP2424511A1 Prevention and treatment of sarcopenia
03/07/2012EP2424509A2 Fixed dose drug combination formulations
03/07/2012EP2424507A1 Compositions and methods for treating insulin resistance and diabetes mellitus
03/07/2012EP2111402B1 Aminopyrazole kinase inhibitors
03/07/2012EP1961767B1 Diagnosis and treatment of cancers and other conditions
03/07/2012EP1919466B1 Formulations for treatment of lipoprotein abnormalities comprising a statin and a methylnicotinamide derivative
03/07/2012EP1653928B1 Spray drying processes for forming solid amorphous dispersions of drugs and polymers
03/07/2012EP1638525B1 Inhalable formulations for treating pulmonary hypertension and methods of using same
03/07/2012EP1355923B1 Immunomodulatory peptides derived from heat shock proteins and uses thereof
03/07/2012EP1348029B1 Materials and methods relating to protein aggregation in neurodegenerative disease
03/07/2012EP1289540B1 Oncomodulin for treating neurological disorders
03/07/2012CN1549721B Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
03/07/2012CN102369009A Co-crystal of etravirine and nicotinamide
03/07/2012CN102366496A Application of Chinese herbal medicine rhizoma alismatis extract in preparation of weight-reducing and lipid-lowering medicaments or in preparation of medicaments with lipase activity inhibition
03/07/2012CN102366433A Application of Chinese medicinal chrysanthemum extract in preparing weight-losing and lipid-lowering medicaments or lipase activity-inhibiting medicaments
03/07/2012CN102366429A Application of extract of Chinese herbal medicine notopterygium root in preparing medicines for reducing weight and fat or medicines having effect of inhibiting lipase activity
03/07/2012CN102366428A Applications of extracts from Chinese herbal medicine Oroxylum indicum in preparation of slimming and lipid lowering medicine or preparation of medicine with inhibition effect on activity of lipase
03/07/2012CN101836963B Medicinal application preparation for curing hypertension
03/07/2012CN101198320B Herpesvirus-derived therapeutic agent for pain
03/06/2012US8129360 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids
03/06/2012US8129351 for treatment of atopic conditions (dermatitis, allergies) and influenza virus; point mutations
03/06/2012US8129342 High purity lipopeptides
03/06/2012US8129332 Reagents and methods for smooth muscle therapies
03/06/2012US8129331 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT
03/06/2012US8129185 Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
03/06/2012US8129132 Using glutamate decarboxylase concentration as diagnostic indicator of autoimmune and connective tissue disorders
03/06/2012US8129112 Polymorphisms in the human CYP2D6 gene promoter region and their use in diagnostic and therapeutic applications
03/06/2012US8128955 Food compositions containing creatine
03/06/2012CA2540225C Solid preparation of pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester
03/06/2012CA2530632C Inhalable formulations for treating pulmonary hypertension and methods of using same
03/06/2012CA2487734C Treatment with cytokines for alzheimer's disease
03/06/2012CA2480666C Tnp-470 polymer conjugates and use thereof
03/06/2012CA2446705C Compositions of quinoxaline-based therapeutic agents and fatty acids having enhanced pharmacokinetic characteristics
03/06/2012CA2446550C Abuse-resistant controlled-release opioid dosage form
03/06/2012CA2445664C Use of il-18 inhibitors for treating or preventing cns injuries
03/01/2012WO2012026614A1 Composition suppressing matrix-metalloproteinase activity
03/01/2012WO2012026609A1 Aqueous composition for ophthalmic administration
03/01/2012WO2012026511A1 Pharmaceutical composition
03/01/2012WO2011093814A3 A pharmaceutical combination comprising formoterol and ciclesonide
03/01/2012WO2011053265A3 The parmaceutical compositions comprising calcium and vitamin d
03/01/2012WO2011005811A8 Combination therapy for the treatment of diabetes
03/01/2012US20120053253 Gene signatures for cancer prognosis
03/01/2012US20120053058 Particles comprising a biopolymer which is degradable under the effect of an electromagnetic wave as emitted by a solar radiation
03/01/2012US20120052116 Immunogenic epitopes of ngep antigen
02/2012
02/29/2012EP2423685A1 Agent and method for diagnosis on the occurrence of Alzheimer's disease
02/29/2012EP2422815A1 Pharmaceutical composition of tegafur and natural flavonoid derivative catechin for potentiating antitumour effect and for treating tumours
02/29/2012EP2422814A1 Remedy for cartilage-related diseases
02/29/2012EP2422813A1 Agent for regulating composition ratio of intestinal bacterial flora
02/29/2012EP2421548A1 Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy
02/29/2012EP2421531A1 Use of nifuratel to treat infections caused by atopobium species
02/29/2012EP2421515A2 Particulate pharmaceutical composition having an opioid and an opioid antagonist
02/29/2012EP2421367A1 Allantoin administration for the treatment of neurodegenerative disease and neurotrauma
02/29/2012EP2007429B1 Oral formulation with beneficial cardiovascular effects, comprising berberine
02/29/2012EP1638567B1 Composition comprising a pulmonary surfactant and sildenafil for the treatment of lung diseases
02/29/2012EP1532153B1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
02/29/2012EP1465642B1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium
02/29/2012EP1390383B1 Antisense permeation enhancers
02/29/2012EP1248604B2 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
02/29/2012CN1972678B Steroid intraocular implants having an extended sustained release for a period of greater than two months
02/29/2012CN1968713B Method of regenerating follicles by inhibiting gene capable of inhibiting follicle formation or activating gene capable of inducing follicle formation
02/29/2012CN102365110A Binary and tertiary galvanic particulates and methods of manufacturing and use thereof
02/29/2012CN102365098A Finely pulverized pharmaceutical composition
02/29/2012CN102362886A Use of extract of liquoric root Chinese herbal medicine in preparation of medicines for reducing weight and fat or medicines capable of inhibiting activity of lipase
02/29/2012CN101926999B Hemostatic disinfectant and preparation method thereof
02/29/2012CN101759882B Sephadex magnetic composite particles and preparation and use thereof
02/29/2012CN101267830B Growth hormone secretagogues
02/29/2012CN101259287B Application of LDP protein as tumor target medicine guiding carrier
02/28/2012US8124650 Antitumor combinations containing taxane derivatives and epidophyllotoxins
02/28/2012US8124640 non-film-coated tablets comprising a mixture of 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole hydrochloride, microcrystalline cellulose, lubricants, colloidal silica and lactose, having stability
02/28/2012US8124638 Tricyclic compounds useful as angiotensin II agonists
02/28/2012US8124614 Steroidal compounds for inhibiting steroid sulphatase
02/28/2012US8124595 Graduated estrogen contraceptive
02/28/2012US8124590 Biodegradable immunomodulatory formulations and methods for use thereof
02/28/2012US8124397 Inactivating pathogens with oxidizing agents for vaccine production
02/28/2012US8124332 Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections
02/28/2012US8124125 Solid dosage form comprising a fibrate
02/28/2012US8124118 Composition comprising biodegradable hydrating ceramics for controlled drug delivery
02/28/2012US8124096 Immune response modifier compositions and methods
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 1151